ITRM

Iterum Therapeutics plc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website iterumtx.com
Employees(FY) 14
ISIN IE000TTOOBX0

Performance

+4.58%

1W

-9.09%

1M

-3.03%

3M

+110.53%

6M

-18.78%

YTD

+44.13%

1Y

Profile

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Advanced Technical Analysis

Technical Analysis of ITRM 2024-05-03

Overview:

In analyzing the technical indicators for ITRM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...

See more ...

Recent News & Updates

2024-05-05 20:00
Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024(Globenewswire)
2024-04-28 20:00
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem(Globenewswire)
2024-04-01 22:22
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-04-01 22:22
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript(Yahoo Finance)
2024-03-29 00:09
Q4 2023 Iterum Therapeutics PLC Earnings Call(Yahoo Finance)
2024-03-27 23:53
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023(Investorplace)
2024-03-27 19:00
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-03-21 04:30
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024(Globenewswire)
2024-03-14 20:00
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat(Globenewswire)
2024-03-06 18:57
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up(Zacks)
2024-03-05 19:00
Iterum Therapeutics Provides Business Update(Globenewswire)
2024-02-01 02:03
Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC(Yahoo Finance)
2024-01-29 18:00
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections(Prnewswire)
2023-12-03 19:00
Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule(Globenewswire)
2023-11-14 23:22
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript(Insidermonkey)
2023-11-14 11:08
Q3 2023 Iterum Therapeutics PLC Earnings Call(Yahoo Finance)
2023-11-13 18:00
Iterum Therapeutics Reports Third Quarter 2023 Financial Results(Globenewswire)
2023-11-06 19:30
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023(Globenewswire)
2023-10-23 20:00
Iterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections(Globenewswire)
2023-10-11 21:15
Iterum Therapeutics to Present Data at IDWeek 2023(Globenewswire)
2023-08-11 10:10
Q2 2023 Iterum Therapeutics PLC Earnings Call(Yahoo Finance)
2023-08-10 19:00
Iterum Therapeutics Reports Second Quarter 2023 Financial Results(Yahoo Finance)
2023-08-04 05:00
Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023(Yahoo Finance)
2023-06-26 21:50
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%(Yahoo Finance)
2023-06-20 20:35
Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera(Yahoo Finance)
2023-06-12 06:23
Iterum Therapeutics to Present Data at ASM Microbe 2023(Yahoo Finance)
2023-05-11 19:00
Iterum Therapeutics Reports First Quarter 2023 Financial Results(Yahoo Finance)
2023-05-09 21:16
Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat(Yahoo Finance)
2023-04-20 05:00
Iterum Therapeutics Presents Scientific Posters at ECCMID 2023 Highlighting Application of Desirability of Outcomes Ranking (DOOR) to two Registration Trials(Yahoo Finance)
2023-04-13 00:00
All You Need to Know About Iterum Therapeutics PLC (ITRM) Rating Upgrade to Strong Buy(Yahoo Finance)

Page 1 of 4

previousnext